Biotech

R&D

Abstract laptop with coloured DNA molecule

Understanding the impact of AI on the advancement of gene th...

The biopharmaceutical landscape stands at the cusp of a transformative era, with artificial intelligence (AI) leading the charge.

News

BridgeBio raises $1.25bn, and other biotech financings

Our round-up of recent biotech financings is headed by a massive $1.25 billion round for genetic medicines specialist BridgeBio Pharma, with smaller rounds for Tr1X, Coman

R&D

Partner Content

Measuring Patient Engagement Summit

Quantifying the Success of Your Patient Engagement Activities to Satisfy Regulatory Requirements, Present ROI to Stakeholders, and Above All Improve the Patient Experience

R&D

JP Morgan 2024 – Jeff Smith

Editor-in-chief Jonah Comstock sat down with Jeff Smith, chief research officer at Precision BioSciences, on the side lines of the JP Morgan Healthcare Conference in San Francisco to discus

R&D

Prediction is very difficult, especially if it’s about the f...

In a new episode of the pharmaphorum podcast, host Nicole Raleigh welcomes Carl Hansen, CEO of AbCellera, for a conversation on the discovery and acceleration of antibody therapeutics.

News

DISCO dances out of the shadows with €20m for ‘surfaceome’

Germany has a new biotech, DISCO Pharmaceuticals, which has announced its presence with €20 million (around $22 million) in seed financing that will be used to advance its